Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of the effective drugs in a alternating
chemotherapy schedules in pretreated patients with mCRC, who have received all effective
drugs.